1,800
Participants
Start Date
April 1, 2022
Primary Completion Date
December 15, 2025
Study Completion Date
December 15, 2025
Follow up of the first known immunization event
"The baseline for enrolment into the study is defined by the occurrence of the first known immunization event, either natural infection or vaccination. The follow-up is planned to last 24 months with respect to this baseline. In subjects with natural infection, the viral variant must be determined for each prospective case by analysis of a nasopharyngeal swab obtained as soon as possible at diagnosis. For historical cases where the variant was not determined and a contemporary nasopharyngeal swab has not been stored, the viral variant may be inferred when a specific variant was dominating the geographic area according to official records available at local health agencies. However, the variant assignment will be labelled as putative, rather than proved.~HCWs can be enrolled in the category of:~(i) vaccination not followed by any later infection, (ii) infection followed by vaccination and (iii) vaccination followed by infection."
RECRUITING
Heinrich Heine university, Düsseldorf
RECRUITING
Azienda Socio-Sanitaria Territoriale Santi Paolo e Carlo, Milan
RECRUITING
Ieo Istituto Europeo Di Oncologia, Milan
RECRUITING
Viesoji Istaiga Vilniaus Uiversiteto Ligoninė Santaros klinikos, Vilnius
RECRUITING
Hospital Juan Ghaham Casasus, Villahermosa
RECRUITING
Centro Hospitalar de Lisboa Ocidental, Lisbon
RECRUITING
Bach Mai Hospital, Hanoi
Centro Hospitalar Lisboa Ocidental
OTHER_GOV
ASST Santi Paolo e Carlo
OTHER
Bach Mai Hospital
OTHER
"Hospital Regional de Alta Especialidad Dr. Juan Graham Casasus"
OTHER
Heinrich-Heine University, Duesseldorf
OTHER
Istituto Europeo di Oncologia
OTHER
Vilnius University Hospital Santaros Klinikos
OTHER
Euresist Network GEIE
OTHER